Sign In
Buy BCS
$24.69
-0.590 (-2.33%)
At Close: Jun 03, 2026
Barclays cuts S&P 500 target, latest on Wall Street to turn bearish
11:53am, Wednesday, 26'th Mar 2025
US stock futures are falling following three days of gains as investors await clarity on the tariff situation. Yahoo Finance Senior Reporter Josh Schafer joins Morning Brief to discuss the broader imp
Barclays Prevails in Two Lawsuits Over $17.7B Securities Overissuance
01:46pm, Tuesday, 25'th Mar 2025
BCS wins dismissal of two U.S. securities fraud lawsuits linked to overissuance of $17.7B debt over regulatory limits as court perceives no intent of fraud.
Barclays promotes Schulte to co-head global investment grade syndicate
01:11pm, Tuesday, 25'th Mar 2025
Barclays has named Scott Schulte global co-head of its investment grade syndicate, whose U.S. unit he had headed since October 2023, an internal memo showed.
BCS vs. EBKDY: Which Stock Is the Better Value Option?
12:40pm, Tuesday, 25'th Mar 2025
Investors interested in Banks - Foreign stocks are likely familiar with Barclays (BCS) and Erste Group Bank AG (EBKDY). But which of these two stocks is more attractive to value investors?
Barclays a top pick among European banks as yield curve 'goes mainstream'
12:08pm, Monday, 24'th Mar 2025
The esoteric economic concept of the yield curve is "becoming more mainstream for investors" in the banking sector, analysts at Keefe, Bruyette and Woods believe, as they tipped Barclays PLC (LSE:BARC
Halcyon Appoints Former Barclays CISO Oliver Newbury as Chief Strategy Officer
11:06am, Monday, 24'th Mar 2025
AUSTIN, Texas--(BUSINESS WIRE)--Halcyon, a leading platform designed from day one to defeat ransomware, today appointed former Barclays CISO Oliver Newbury as Chief Strategy Officer. Newbury, who earl
Barclays beats two lawsuits in US over $17.7 billion issuance blunder
02:53pm, Friday, 21'st Mar 2025
Barclays won the dismissal on Friday of two U.S. securities fraud lawsuits stemming from the British bank's unauthorized sale of $17.7 billion more securities than U.S. regulators allowed.
Barclays Appoints Kieran Whitty as a Co-Head of Healthcare for Europe, Middle East and Africa
04:30am, Thursday, 20'th Mar 2025
LONDON--(BUSINESS WIRE)--Barclays today announces the appointment of Kieran Whitty as Co-Head of Healthcare EMEA (Europe, Middle East and Africa), working alongside Sid Chhibbar, Co-Head of Healthcare
Why Barclays (BCS) is a Great Dividend Stock Right Now
12:45pm, Wednesday, 19'th Mar 2025
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Barclays (BCS) have what it takes?
Barclays: positive Japan wage growth continues despite Trump tariffs
11:00am, Tuesday, 18'th Mar 2025
Naohiko Baba, chief Japan economist at Barclays sees impacts from Trump tariffs on limited to certain sectors of the Japanese economy, such as the automobile sector. With wages outpacing inflation, he
Are Finance Stocks Lagging Barclays (BCS) This Year?
10:46am, Tuesday, 18'th Mar 2025
Here is how Barclays (BCS) and Banco Do Brasil SA (BDORY) have performed compared to their sector so far this year.
Barclays CFO says client returns under tight scrutiny
10:18am, Tuesday, 18'th Mar 2025
Barclays CFO Anna Cross said on Tuesday the bank was continuing to axe unrewarding customer relationships that fell short of expected return targets, as it steps up efforts to direct capital towards h
3 Foreign Bank Stocks to Bet on From a Prospering Industry
09:25am, Tuesday, 18'th Mar 2025
Relatively lower interest rates and business restructuring efforts are likely to support Zacks Foreign Banks Industry stocks like HSBC Holdings, Barclays and NatWest Group amid uneven economic growth
Europe's main issue is impact of tariffs on global economy: Barclays strategist
03:30am, Monday, 17'th Mar 2025
Emmanuel Cau, Barclays' head of European equity strategy, said Europe's main issue is a trade war triggered by U.S. President Donald Trump's tariffs.
DUBLIN and PORTLAND, Ore., March 13, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutio
